Aliberti, Stefano
Chalmers, James D.
Article History
First Online: 9 August 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Speakers/ Advisory boards on bronchiectasis in the past two years for Bayer; Insmed; Chiesi, Menarini, Mundipharma, Glaxosmithkline, Astrazeneca, Grifols, Guidotti, Malesci, Zambon, Actavis, Novartis, Bi, Raptor, Horizon Pharma. In addition. SA and CJD are Guest Editor of the Supplement on Bronchiectasis, whereas SA is Associate editor of Multidisciplinary Respiratory Medicine.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.